Matteo Amicucci
Impact in
- Oncology top 10%
- CAR-T cell therapy research
-
- Neuroblastoma Research and Treatments
Papers in
-
- Childhood Cancer Survivors' Quality of Life 7
- Oncology 9
- COVID-19 and healthcare impacts 7
- CAR-T cell therapy research 2
- Co-authors
- Angela Mastronuzzi (5 shared papers)Valentina Biagioli (3 shared papers)Immacolata Dall’Oglio (5 shared papers)Alberto Eugenio Tozzi (1 shared paper)Luisa Russo (1 shared paper)Elena Fabbri (1 shared paper)Francesco Gesualdo (1 shared paper)Orsola Gawronski (1 shared paper)
- Journals
- Pediatric Blood & Cancer (6 papers)Journal of Clinical Medicine (2 papers)European Journal of Oncology Nursing (2 papers)Journal of Infusion Nursing (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ItalySwitzerlandSpain
In The Last Decade
Matteo Amicucci
17 papers receiving 450 citations
Matteo Amicucci's Hit Papers
Peers
Comparison fields: 5 of 44
- Oncology 305
- Neurology 106
- Immunology 82
- Genetics 59
- Pediatrics, Perinatology and Child Health 37
Countries citing papers authored by Matteo Amicucci
This map shows the geographic impact of Matteo Amicucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Amicucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Amicucci more than expected).
Fields of papers citing papers by Matteo Amicucci
This network shows the impact of papers produced by Matteo Amicucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Amicucci. The network helps show where Matteo Amicucci may publish in the future.
Co-authors
The 25 scholars most cited alongside Matteo Amicucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma Hit paper breakdown → | 2023 | 400 |
| 2 | 2020 | 10 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 7 | |
| 5 | 2020 | 7 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2020 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2023 | 0 | |
| 19 | 2025 | 0 |
About Matteo Amicucci
Matteo Amicucci is a scholar working on Pediatrics, Perinatology and Child Health, Oncology, Public Health, Environmental and Occupational Health, General Health Professions and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 461 indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (7 papers), COVID-19 and healthcare impacts (7 papers), COVID-19 Clinical Research Studies (2 papers), CAR-T cell therapy research (2 papers), Child and Adolescent Health (2 papers), COVID-19 and Mental Health (2 papers), Infection Control and Ventilation (1 paper) and Music Therapy and Health (1 paper). The work is most often cited by research in Oncology (305 citations), Neurology (106 citations), Immunology (82 citations), Genetics (59 citations) and Pediatrics, Perinatology and Child Health (37 citations). Matteo Amicucci has collaborated with scholars based in Italy, Switzerland and Spain. Frequent co-authors include Angela Mastronuzzi, Valentina Biagioli, Immacolata Dall’Oglio, Alberto Eugenio Tozzi, Luisa Russo, Elena Fabbri, Francesco Gesualdo, Orsola Gawronski, Maria Antonietta De Ioris and Ileana Croci. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Medicine, European Journal of Oncology Nursing, Journal of Infusion Nursing and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.